Atlas Trials

Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis

Clinical trial NCT00743678 · COMPLETED

Trial details

NCT number
NCT00743678
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal CancerUnresectable Liver Metastasis
Start date
2008-06-01
Primary completion
2012-01-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.